The intimate connections and regulatory relationships between VEGFR and PI3K/Pten signaling in tumors motivate us to investigate the joint prognostic value of VEGFR and components involved in the PI3K/Pten pathway on breast cancer clinical outcome. This evidence concerns the gene KDR and breast carcinoma.